Gary D. Gentzkow
Direttore Tecnico/Scientifico/R&S presso Theregen, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Timothy C. Mills | M | 68 |
Theregen, Inc.
 Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | - |
| Jose-Carlos Gutiérrez-Ramos | M | 61 |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | - |
| Gilbert R. Mintz | M | - |
Theregen, Inc.
Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | - |
| Gianine M. Figliozzi | F | - |
Theregen, Inc.
Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | - |
| Rob A. Abrams | M | - |
Theregen, Inc.
Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | - |
| Elizabeth Gordon | M | - |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 6 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Gary D. Gentzkow
- Contatti personali
